ABSTRACT -A fraction from a boiled scallop extract modified by a sonication procedure exhibited marked antitumor activity when it was injected intradermally into either ICR or C3H/He mice that had been given sc implants of sarcoma 180 and Ehrlich carcinoma. The active moiety was heat-stable and noncytotoxic. In contrast, preparations from raw scallop showed lower antitumor activity and were heat-Iablle.-J Natl Cancer Inst 60: 1499-1500, 1978.
The study of the stimulation of host defense mechanisms against experimental tumors has for several years been part of a broad program seeking effective agents that can stimulate the host's immunologic defenses against neoplastic growth. Most antitumor agents of known structure are small to medium-size molecules of low molecular weight. However, some macromolecular substances have attracted interest because of their antitumor activity and their relatively low toxicity.
The total or partial regression of experimental tumors in mice and hamsters following treatment with macro molecular extracts of the marine clam Mercenaria mercenaria was described in (1) . This report is of particular relevance to our present studies.
MATERIALS AND METHODS
We prepared a heat-stable and noncytotoxic antitumor fraction from Patinopecten yessoensis, an edible cultured scallop found in Japanese coastal waters. We boiled fresh scallops in their shells at 100° C for 10 minutes and, after removing the shells, froze them at -60° C until use. The scallop extracts showing antitumor activity were prepared from whole scallops minus the liver (digestive diverticulum), inasmuch as the isolated liver from the boiled scallop showed no antitumor activity under the present assay system. The procedure for the preparation of the extract is summarized in textfigure 1.
Although some components of the scallop extract (fractions 1 and 2) were inactive, fraction 4, prepared from the inactive fraction I by means of sonication, showed strong antitumor activity against sarcoma 180 and Ehrlich carcinoma in ICR mice. Even when this fraction was autoclaved or heated at 100° C for 30 minutes, it did not lose its antitumor activity. Moreover, fraction 4 exhibited a high inhibition ratio against sarcoma 180 transplanted into C3H/He mice. With the use of the procedure described in text-figure I, the yield of dried fraction 4 was approximately 0.96% of the scallop (by weight).
The respective tumor cells (6X 10 6 ) were injected sc into the right flanks of ICR mice. Samples to be tested distilled H20. were injected into the tumor site on days 7, 9, and 11 after tumor inoculation, by which time the tumors had reached an average diameter of 6 mm. We charted the rate of tumor growth weekly for 5 weeks, using as a comparison the rate of tumor growth in the control mice. No tumor spontaneously regressed. At the end of week 5, the mice were killed and the tumors dissected out and weighed. The inhibition ratios were calculated by use of the following formula:
where A is the average tumor weight of the control group and B is that of the treated group. Complete regression indicates the ratio of the number of mice showing complete tumor regression to the total number of mice tested. An inhibition ratio of 93.7% was observed with sarcoma 180 in ICR mice when they were treated with fraction 4; the autoclaved fraction 4 gave essentially the same value. 3 Chemotherapy Division, National Cancer Center Research Institute, Tsukiji 5-chome, Chuo-ku. Tokyo, Japan 104. 4 We thank Dr. P. Howgate, Biochemistry Department, University of the Witwaterstrand, Johannesburg, South Africa, for his assistance in preparing this manuscript. SASAKI, TAKASUKA, AND ABIKO was high. In a smaller dose (100 mg/kg), fraction 4 was still effective but showed a decrease in its activity; it had an inhibition ratio of 74.2% and caused complete tumor regression in 2 of 5 mice. However, fractions I, 2, and 3 were ineffective even at a high dose level (1,200 mg/kg). Fraction 4 and autoclaved fraction 4 both showed a strong antitumor effect against sarcoma 180 transplanted into C3H/He mice, which are known to have a low immune response. The number of tumors completely regressing was also high in this system. The inhibition ratio observed with Ehrlich carcinoma (73.5%) was less than the high values achieved with sarcoma 180 but was still significant. In a preliminary study on antitumor spectra, however, fraction 4 was almost ineffective against Ll210 cells (4 X 10 4 ) transplanted ip into (BALB/c X DBA)Fl mice by consecutive ip injections at a level of 90 mg fraction 4/kg for 5 days; the T /C value, calculated on the basis of the mean survival time of treated (T) versus control (C) animals, was 125%. Toxicity at the doses of samples we used was not detectable (table 1) .
RESULTS AND DISCUSSION
The results of further fractionation and purification of fraction 4 with the use of Diaflo ultrafiltration membranes, Sephadex and DEAE-Sepharose column chromatography, and preparative gel electrophoresis revealed that it contained at least two active principlesone was probably a protein (mol wt, =21,000 daltons) that lost its activity when heated or after treatment with pronase, and the other was probably a peptidoglycan J NATL CANCER INST (mol wt, = 100,000 daltons) that did not lose its activity after either pronase or heat treatment. Element analysis of the latter fraction indicated that it was made up of: C, 30.10; H, 5.12; N, 7.55; S, 0.47; and P, 7.41. The specific rotation was [a]t3 0° (c=0.03, in H 2 0 or 10% NaOH). Total carbohydrate content was 16.1 % as glucose, as ascertained by the method of Dubois et al. (2) . Further structural studies on the active principle of fraction 4 will be detailed in a later publication.
To examine whether fraction 4 had a direct cytocidal effect on tumor cells, we cultured ascites cells of sarcoma' 180 for 24 hours in Eagle's minimum essential medium containing 1 mg fraction 4/ml medium and examined the viability of the tumor cells by trypan blue staining. Our results revealed 100% cell viability, which did not differ from that of tumor cells cultured in the same medium without fraction 4. Furthermore, the cells incubated the same way as above, except with medium containing 5 mg fraction 4, were washed three times with the same medium and 6x 10 6 cells were transplanted sc into the right flanks of ICR mice. After 5 weeks, the weights of the solid tumors averaged 5.2 g, compared with 5.0 g which resulted from transplantation of control cells incubated in a medium without fraction 4. This result indicates that the cultivation of the cells with fraction 4 did not have any inhibitory effect on tumor growth.
Fractions 2 and 4 (mol wt, <300,000 daltons), obtained from extracts of raw scallop including liver, showed no antitumor activity. However, fractions 1 and 3 (mol wt, >300,000 daltons) in the sarcoma 180-ICR mouse system produced inhibition ratios of 58.4 and 56.8%, respectively, and no tumor completely regressed. These results revealed that treatment of raw scallop extract by sonication did not enhance its antitumor activity.
When fractions 1 and 3 (raw scallop) were heated at 100° C for 20 minutes, activity was lost, resulting in inhibition ratios of 16.2 and 11.0%, respectively. Despite the paucity of direct evidence, these findings suggest that an extract of a raw scallop, with or without sonication treatment, may be similar in its biologic and chemical properties to a clam extract (1 ) .
The antitumor activity exhibited by the boiled scallop extract is a novel example of biologic interaction.
